Dural Arteriovenous Fistulas: Baseline Cognitive Changes and Changes following Treatment: A Prospective Longitudinal Study

References

1. 1.↵
   1. Brito A,
   2. Tsang AC,
   3. Hilditch C

   , et al. Intracranial dural arteriovenous fistula as a reversible cause of dementia: case series and literature review. World Neurosurg 2019:121:e543–53 doi:10.1016/j.wneu.2018.09.161 pmid:30268554

   CrossRefPubMed
2. 2.↵
   1. Velz J,
   2. Kulcsar Z,
   3. Büchele F, et al

   . The challenging clinical management of patients with cranial dural arteriovenous fistula and secondary Parkinson’s syndrome: pathophysiology and treatment options. Cerebrovasc Dis Extra 2020;10:124–38 doi:10.1159/000510597 pmid:33091906

   CrossRefPubMed
3. 3.↵
   1. Holekamp TF,
   2. Mollman ME,
   3. Murphy RK, et al

   . Dural arteriovenous fistula-induced thalamic dementia: report of 4 cases. J Neurosurg 2016;124:1752–65 doi:10.3171/2015.5.JNS15473 pmid:26587655

   CrossRefPubMed
4. 4.↵
   1. Luo Y,
   2. Qi J,
   3. Cen Z, et al

   . Two cases of dural arteriovenous fistula presenting with parkinsonism and progressive cognitive dysfunction. J Neurol Sci 2014;343:211–14 doi:10.1016/j.jns.2014.05.059 pmid:24928082

   CrossRefPubMed
5. 5.↵
   1. Alexandratou A,
   2. Mah Y,
   3. Ramsey D, et al

   . Dural arteriovenous fistula causing reversible cognitive impairment. Pract Neurol 2022;23:82–84 doi:10.1136/pn-2021-003332 pmid:35981860

   CrossRefPubMed
6. 6.↵
   1. Netravathi M,
   2. Pal PK,
   3. Bharath RD, et al

   . Intracranial dural arteriovenous fistula presenting as parkinsonism and cognitive dysfunction. J Clin Neurosci 2011;18:138–40 doi:10.1016/j.jocn.2010.04.047 pmid:20851606

   CrossRefPubMed
7. 7.↵
   1. Han Z,
   2. Yang H,
   3. Du Y, et al

   . Progressive cognitive decline with bithalamic and basal ganglia lesions caused by dural arteriovenous fistula. Neurology 2021;97:738–39 doi:10.1212/WNL.0000000000012677 pmid:34408074

   CrossRefPubMed
8. 8.↵
   1. Xie J,
   2. Zhang T,
   3. Zhang Y, et al

   . Dural arteriovenous fistula with progressive dementia and parkinsonism: two case reports and a literature review. Medicine (Baltimore) 2023;102:E35782 doi:10.1097/MD.0000000000035782 pmid:37960814

   CrossRefPubMed
9. 9.↵
   1. Racine CA,
   2. Lawton MT,
   3. Hetts SW, et al

   . Neuropyschological profile of reversible cognitive impairment in a patient with a dural arteriovenous fistula. Neurocase 2008;14:231–38 doi:10.1080/13554790802232677 pmid:18609005

   CrossRefPubMed
10. 10.↵
    1. Wilson M,
    2. Doran M,
    3. Enevoldson TP, et al

    . Cognitive profiles associated with intracranial dural arteriovenous fistula. Age Ageing 2010;39:389–92 doi:10.1093/ageing/afq017 pmid:20178995

    CrossRefPubMed
11. 11.↵
    1. Sekar S,
    2. Kannath SK,
    3. Ramachandran S, et al

    . Alterations in resting-state functional MRI connectivity related to cognitive changes in intracranial dural arteriovenous fistulas before and after embolization treatment. J Magn Reson Imaging 2022;55:1183–99 doi:10.1002/jmri.27936 pmid:34592019

    CrossRefPubMed
12. 12.↵
    1. Gramegna LL,
    2. Ortega G,
    3. Dinia L, et al

    . Cognitive improvement following endovascular embolization in patients with intracranial dural arteriovenous fistula: the Neuropsychology in dural ArterIal Fistula (NAIF) Study. J Neurointerv Surg 2023 Dec 7. [Epub ahead of print] doi:10.1136/jnis-2023-021033 pmid:8071581

    CrossRefPubMed
13. 13.↵
    1. Anokhin AP,
    2. Luciana M,
    3. Banich M, et al

    . Age-related changes and longitudinal stability of individual differences in ABCD neurocognition measures. Dev Cogn Neurosci 2022;54:101078 doi:10.1016/j.dcn.2022.101078 pmid:35123342

    CrossRefPubMed
14. 14.↵
    1. Tröster AI,
    2. Woods SP,
    3. Morgan EE

    . Assessing cognitive change in Parkinson’s disease: development of practice effect-corrected reliable change indices. Arch Clin Neuropsychol 2007;22:711–18 doi:10.1016/j.acn.2007.05.004 pmid:17644304

    CrossRefPubMed
15. 15.↵
    1. Slade PD,
    2. Townes BD,
    3. Rosenbaum G, et al

    . The serial use of child neurocognitive tests: development versus practice effects. Psychol Assess 2008;20:361–69 doi:10.1037/a0012950 pmid:19086759

    CrossRefPubMed
16. 16.↵
    1. Shura RD,
    2. Brearly TW,
    3. Rowland JA, et al

    . RBANS validity indices: a systematic review and meta-analysis. Neuropsychol Rev 2018;28:269–84 doi:10.1007/s11065-018-9377-5 pmid:29770912

    CrossRefPubMed
17. 17.↵
    1. Novitski J,
    2. Steele S,
    3. Karantzoulis S, et al

    . The repeatable battery for the assessment of neuropsychological status effort scale. Arch Clin Neuropsychol 2012;27:190–95 doi:10.1093/arclin/acr119 pmid:22277124

    CrossRefPubMed
18. 18.↵
    1. Speer DC

    . Clinically significant change: Jacobson and Truax (1991) revisited. J Consult Clin Psychol 1992;60:402–08 doi:10.1037//0022-006x.60.3.402 pmid:1619094

    CrossRefPubMed
19. 19.↵
    1. Sherman E,
    2. Hrabok M

    . A Compendium of Neuropsychological Tests. New York: Oxford University Press; 2006
20. 20.↵
    1. Tombaugh TN

    . Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 2004;19:203–14 doi:10.1016/S0887-6177(03)00039-8 pmid:15010086

    CrossRefPubMed
21. 21.↵
    1. Chen PM,
    2. Olson SE,
    3. Handwerker J

    . Bithalamic lesions: cranial dural arteriovenous fistula manifesting as thalamic dementia. Stroke 2020;51:E355–58 doi:10.1161/STROKEAHA.120.030576 pmid:33131425

    CrossRefPubMed
22. 22.↵
    1. Sanchez S,
    2. Wendt L,
    3. Hayakawa M, et al

    . Dural arteriovenous fistulas with cognitive impairment: angiographic characteristics and treatment outcomes. Neurosurgery 2023 Dec 14. [Epub ahead of print] doi:10.1227/neu.0000000000002802

    CrossRef